ReviewContemporary oncology (Poznan, Poland)2014

Trabectedin as a single agent and in combination with pegylated liposomal doxorubicin - activity against ovarian cancer cells.

Agnieszka Marczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.